Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
31/03/2026 EBITDA margin at 7.6%, in line with the targetNet income impacted by significant non-cash depreciations,strongly positive Free Cash Flow (+€36.6m) and sharp reduction in net debt Moderate...
-
RENO, Nev., March 31, 2026 (GLOBE NEWSWIRE) -- ITS Logistics, an Echo Global Logistics company, released the March ITS Supply Chain Report. This month, the report confirms that rates for both van...
-
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”) today announced that it has entered into an Investment Cooperation Agreement with...
-
MGH collaboration to evaluate TRE-515 in ALS patients, advancing development of a first-in-class therapy targeting inflammation and nucleotide metabolism.
-
Cary, NC, March 31, 2026 (GLOBE NEWSWIRE) -- INE Security, a global leader in cybersecurity training and certification, today announced the launch of the newly updated Junior Penetration Tester...
-
Hiboy announced its expansion into major brick-and-mortar retail channels, including Costco, Best Buy, and Target, marking a new phase for the brand.
-
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical mineral mining company, today announced that the...
-
NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development, Company announces the appointment of Pamela Vig, Ph.D.
-
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The defense world is starting to treat drones less like one-time purchases and more like a service you can...
-
Preclinical data demonstrate deep and durable tumor regressions with lead product candidate ERNA-101 in combination with PD-1 Blockade in ovarian cancer IND submission for ERNA-101 expected in Q3...